Human acute myeloid leukemia stem cells

Archives of Medical Research

Volumn 34, Issue 6, 2003, Pages 507-514

  Hope, Kristin J ^a   Jin, Liqing ^a   Dick, John E ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

AML; Gene transfer; Hematopoiesis; Lentivirus; NOD SCID; SL IC; SRC

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB; IMMUNOTOXIN;

ACUTE LEUKEMIA; CELL CLONE; CELL DEATH; CELL RENEWAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MYELOID LEUKEMIA; NONHUMAN; PHENOTYPE; REVIEW; STEM CELL; XENOGRAFT;

EID: 0346374774     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.08.007     Document Type: Review

References (64)

1. th ed. Hematology of infancy and childhood. Vol. 2:1993;1288-1318 W.B. Saunders Co, Philadelphia, PA, USA.
2. McCulloch E. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture). Blood. 62:1983;1-13.
3. Griffin J., Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood. 68:1986;1185-1195.
4. Lozzio B.B., Machado E.A., Lozzio C.B., Lair S. Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells. J Exp Med. 143:1976;225-231.
5. Lozzio B.B., Lozzio C.B., Machado E. Human myelogenous (Ph1+) leukemia cell line: transplantation into athymic mice. JNCI. 56:1976;627-629.
6. Franks C.R., Bishop D., Balkwill F.R., Oliver R.T.D., Spector W.G. Growth of acute myeloid leukemia as discrete subcutaneous tumours in immune-deprived mice. Br J Cancer. 35:1977;697-700.
7. Machado E.A., Gerard D.A., Lozzio C.B., Lozzio B.B., Mitchell J.R., Golde D.W. Proliferation and differentiation of human myeloid leukemia cells in immunodeficient mice: electron microscopy and cytochemistry. Blood. 63:1984;1015-1022.
8. Nilsson K., Giovanella B.C., Stehlin J.S., Klein G. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer. 19:1977;337-344.
9. Watanabe S., Shimosato Y., Kuroki M., Sato Y., Nakajima T. Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice. Cancer Res. 40:1980;2588-2595.
10. Clutterbuck R.D., Hills C.A., Hoey P., Alexander P., Powles R.L., Millar J.L. Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: comparison with cells in short-term culture. Leuk Res. 9:1985;1511-1518.
11. Ghose T., Lee C.L., Faulkner G., Fernandez L.A., Lee S.H. Progression of a human B cell chronic lymphocytic leukemia line in nude mice. Am J Hematol. 28:1988;146-154.
12. Namikawa R., Ueda R., Kyoizumi S. Growth of human myeloid leukemia in the human marrow environment of SCID-hu mice. Blood. 82:1993;2526-2536.
13. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Cáceres-Cortés J., Minden M., Paterson B., Caligiuri M., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367:1994;645-648.
14. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 3:1997;730-737.
15. Larochelle A., Vormoor J., Lapidot T., Sher G., Furukawa T., Li Q., Shultz L., Oliveri N.F., Stamatoyannopoulos G., Dick J.E. Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Genet. 4:1995;163-172.
16. Cashman J.D., Lapidot T., Wang J.C., Doedens M., Shultz L.D., Lansdorp P., Dick J.E., Eaves C.J. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 89:1997;4307-4316.
17. Fialkow P.J., Singer J.W., Adamson J.W., Vaidya K., Dow L.W., Ochs J., Moohr J.W. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 57:1981;1068-1073.
18. Fialkow P., Singer J., Raskind W., Adamson J., Jacobson R., Bernstein I., Najfeld V., Veith R. Clonal development, stem-cell differentiation, and clinical remission in acute nonlymphocytic leukemia. N Engl J Med. 317:1987;468-473.
19. Keinänen M., Griffin J., Bloomfield C., Machnicki J., de la Chapelle A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. N Engl J Med. 318:1988;1153-1158.
20. Bernstein I.D., Singer J.W., Smith F.O., Andrews R.G., Flowers D.A., Petersens J., Steinmann L., Najfeld V., Savage D., Fruchtman S. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood. 79:1992;1811-1816.
21. Raymakers R., Wittebol S., Pennings A., Linders E., Poddighe P., De Witte T. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+). Leukemia. 9:1995;450-457.
22. Raskind W.H., Steinmann L., Najfeld V. Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer. Leukemia. 12:1998;108-116.
23. Haase D., Feuring-Buske M., Konemann S., Fonatsch C., Troff C., Verbeek W., Pekrun A., Hiddemann W., Wormann B. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood. 86:1995;2906-2912.
24. Mehrotra B., George T.I., Kavanau K., Avet-Loiseau H., Moore D. 2nd, Willman C.L., Slovak M.L., Atwater S., Head D.R., Pallavicini M.G. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood. 86:1995;1139-1147.
25. Ailles L.E., Gerhard B., Kawagoe H., Hogge D.E. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood. 94:1999;1761-1772.
26. Rombouts W.J., Martens A.C., Ploemacher R.E. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model. Leukemia. 14:2000;889-897.
27. Turhan A.G., Lemoine F.M., Debert C., Bonnet M.L., Baillou C., Picard F., Macintyre E.A., Varet B. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 85:1995;2154-2161.
28. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood. 89:1997;3104-3112.
29. Brendel C., Mohr B., Schimmelpfennig C., Muller J., Bornhauser M., Schmidt M., Ritter M., Ehninger G., Neubauer A. Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias. Leukemia. 13:1999;1770-1775.
30. Miyamoto T., Weissman I.L., Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA. 97:2000;7521-7526.
31. Jordan C.T., Upchurch D., Szilvassy S.J., Guzman M.L., Howard D.S., Pettigrew A.L., Meyerrose T., Rossi R., Grimes B., Rizzieri D.A., Luger S.M., Phillips G.L. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 14:2000;1777-1784.
32. Terpstra W., Prins A., Ploemacher R.E., Wognum B.W., Wagemaker G., Lowenberg B., Wielenga J.J. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood. 87:1996;2187-2194.
33. Blair A., Sutherland H.J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol. 28:2000;660-671.
34. Feuring-Buske M., Hogge D.E. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia. Blood. 97:2001;3882-3889.
35. Guan Y., Hogge D.E. Proliferative status of primitive hematopoietic progenitors from patients with acute myelogenous leukemia (AML). Leukemia. 14:2000;2135-2141.
36. Ailles L.E., Humphries R.K., Thomas T.E., Hogge D.E. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice. Exp Hematol. 27:1999;1609-1620.
37. Terpstra W., Ploemacher R.E., Prins A., van Lom K., Pouwels K., Wognum A.W., Wagemaker G., Lowenberg B., Wielenga J.J. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood. 88:1996;1944-1950.
38. Guzmán M.L., Neering S.J., Upchurch D., Grimes B., Howard D.S., Rizzieri D.A., Luger S.M., Jordan C.T. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 98:2001;2301-2307.
39. Jones D.R., Broad R.M., Madrid L.V., Baldwin A.S. Jr., Mayo M.W. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann Thorac Surg. 70:2000;930-936. discussion 936-937.
40. Wang W., Abbruzzese J.L., Evans D.B., Larry L., Cleary K.R., Chiao P.J. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res. 5:1999;119-127.
41. Shattuck-Brandt R.L., Richmond A. Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. Cancer Res. 57:1997;3032-3039.
42. Kordes U., Krappmann D., Heissmeyer V., Ludwig W.D., Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia. 14:2000;399-402.
43. Lessard J., Baban S., Sauvageau G. Stage-specific expression of polycomb group genes in human bone marrow cells. Blood. 91:1998;1216-1224.
44. Park I.K., He Y., Lin F., Laerum O.D., Tian Q., Bumgarner R., Klug C.A., Li K., Kuhr C., Doyle M.J., Xie T., Schummer M., Sun Y., Goldsmith A., Clarke M.F., Weissman I.L., Hood L., Li L. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 99:2002;488-498.
45. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukemic stem cells. Nature. 423:(6937):2003;255-260.
46. Sauvageau G., Thorsteinsdottir U., Eaves C.J., Lawrence H.J., Largman C., Lansdorp P.M., Humphries R.K. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1995;1753-1765.
47. Kroon E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A., Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:1998;3714-3725.
48. Thorsteinsdottir U., Sauvageau G., Humphries R.K. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol Oncol Clin North Am. 11:1997;1221-1237.
49. Park I.K., Qian D., Kiel M., Becker M., Pihalja M., Weissman I.L., Morrison S.J., Clarke M. Bmi-1 is required for maintenance of adult self-renewing hematopoietic stem cells. Nature. 2003;. in press.
50. Dick J.E. Stem cells: self-renewal writ in blood. Nature. 423:2003;231-233.
51. Terpstra W., Rozemuller H., Breems D.A., Rombouts E.J., Prins A., FitzGerald D.J., Kreitman R.J., Wielenga J.J., Ploemacher R.E., Lowenberg B., Hagenbeek A., Martens A.C. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells. Blood. 90:1997;3735-3742.
52. Rozemuller H., Terpstra W., Rombouts E.J., Lawler M., Byrne C., FitzGerald D.J., Kreitman R.J., Wielenga J.J., Lowenberg B., Touw I.P., Hagenbeek A., Martens A.C. GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF. Leukemia. 12:1998;1962-1970.
53. Feuring-Buske M., Frankel A., Gerhard B., Hogge D. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells. Exp Hematol. 28:2000;1390-1400.
54. de Bueger M., Bakker A., Van Rood J.J., Van der Woude F., Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol. 149:1992;1788-1794.
55. Dolstra H., Fredrix H., Preijers F., Goulmy E., Figdor C.G., de Witte T.M., van de Wiel-van Kemenade E. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol. 158:1997;560-565.
56. Warren E.H., Gavin M., Greenberg P.D., Riddell S.R. Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. Curr Opin Hematol. 5:1998;429-433.
57. Falkenburg J.H., Goselink H.M., van der Harst D., van Luxemburg-Heijs S.A., Kooy-Winkelaar Y.M., Faber L.M., de Kroon J., Brand A., Fibbe W.E., Willemze R., Goulmy E. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Exp Med. 174:1991;27-33.
58. Niederwieser D., Grassegger A., Aubock J., Herold M., Nachbaur D., Rosenmayr A., Gachter A., Nussbaumer W., Gaggl S., Ritter M. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood. 81:1993;2200-2208.
59. Faber L.M., van der Hoeven J., Goulmy E., Hooftman-den Otter A.L., van Luxemburg-Heijs S.A., Willemze R., Falkenburg J.H. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Clin Invest. 96:1995;877-883.
60. Bonnet D., Warren E.H., Greenberg P.D., Dick J.E., Riddell S.R. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc Natl Acad Sci USA. 96:1999;8639-8644.
61. Guzmán M.L., Swiderski C.F., Howard D.S., Grimes B.A., Rossi R.M., Szilvassy S.J., Jordan C.T. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA. 99:2002;16220-16225.
62. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111.
63. Dick J.E. Breast cancer stem cells revealed. Proc Natl Acad Sci USA. 100:2003;3547-3549.
64. Al-Hajj M., Wicha M., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:(7):2003;3983-3988.